ANGLE plc ‘well on track’ for commercial revenues

ANGLE plc chief executive Andrew Newland tells IG that the company is making excellent progress with its Parsortix cell separation system. 

The company is now working with nine key opinion leaders to develop a pipeline for the application of the medical diagnostic device.

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.